Literature DB >> 23100496

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Helen E Jenkins1, Valeriu Plesca, Anisoara Ciobanu, Valeriu Crudu, Irina Galusca, Viorel Soltan, Aliona Serbulenco, Matteo Zignol, Andrei Dadu, Masoud Dara, Ted Cohen.   

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is a major concern in countries of the former Soviet Union. The reported risk of resistance among tuberculosis (TB) cases in the Republic of Moldova is among the highest in the world. We aimed to produce high-resolution spatial maps of MDR-TB risk and burden in this setting. We analysed national TB surveillance data collected between 2007 and 2010 in Moldova. High drug susceptibility testing coverage and detailed location data permitted identification of subregional areas of higher MDR-TB risk. We investigated whether the distribution of cases with MDR-TB risk factors could explain this observed spatial variation in MDR-TB. 3447 MDR-TB cases were notified during this period; 24% of new and 62% of previously treated patients had MDR-TB. Nationally, the estimated annual MDR-TB incidence was 54 cases per 100 000 persons and >1000 cases per 100 000 persons within penitentiaries. We identified substantial geographical variation in MDR-TB burden and hotspots of MDR-TB. Locations with a higher percentage of previously incarcerated TB cases were at greater risk of being MDR-TB hotspots. Spatial analyses revealed striking geographical heterogeneity of MDR-TB. Methods to identify locations of high MDR-TB risk and burden should allow for better resource allocation and more appropriate targeting of studies to understand local mechanisms driving resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100496      PMCID: PMC3800490          DOI: 10.1183/09031936.00111812

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Increasing tuberculosis case detection: lessons from the Republic of Moldova.

Authors:  Viorel Soltan; Asma Khalid Henry; Valeriu Crudu; Irina Zatusevski
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

2.  Linking surveillance with action against drug-resistant tuberculosis.

Authors:  Ted Cohen; Justin Manjourides; Bethany Hedt-Gauthier
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

Review 3.  Pitfalls of tuberculosis programmes in prisons.

Authors:  H Reyes; R Coninx
Journal:  BMJ       Date:  1997-11-29

4.  Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.

Authors:  M Ruddy; Y Balabanova; C Graham; I Fedorin; N Malomanova; E Elisarova; S Kuznetznov; G Gusarova; S Zakharova; A Melentyev; E Krukova; V Golishevskaya; V Erokhin; I Dorozhkova; F Drobniewski
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

5.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Authors:  M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

6.  Challenges in estimating the total burden of drug-resistant tuberculosis.

Authors:  Ted Cohen; Caroline Colijn; Abigail Wright; Matteo Zignol; Alexander Pym; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

7.  Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?

Authors:  I Dubrovina; K Miskinis; S Lyepshina; Y Yann; H Hoffmann; R Zaleskis; P Nunn; M Zignol
Journal:  Int J Tuberc Lung Dis       Date:  2008-07       Impact factor: 2.373

Review 8.  HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Authors:  Charles D Wells; J Peter Cegielski; Lisa J Nelson; Kayla F Laserson; Timothy H Holtz; Alyssa Finlay; Kenneth G Castro; Karin Weyer
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

9.  Tools from ecology: useful for evaluating infection risk models?

Authors:  Simon Brooker; Simon I Hay; Don A P Bundy
Journal:  Trends Parasitol       Date:  2002-02

10.  Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Authors:  Alena Skrahina; Henadz Hurevich; Aksana Zalutskaya; Evgeni Sahalchyk; Andrei Astrauko; Wayne van Gemert; Sven Hoffner; Valiantsin Rusovich; Matteo Zignol
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

View more
  35 in total

Review 1.  Global and Regional Burden of Isoniazid-Resistant Tuberculosis.

Authors:  Courtney M Yuen; Helen E Jenkins; Carly A Rodriguez; Salmaan Keshavjee; Mercedes C Becerra
Journal:  Pediatrics       Date:  2015-06-01       Impact factor: 7.124

Review 2.  Transforming the fight against tuberculosis: targeting catalysts of transmission.

Authors:  David W Dowdy; Andrew S Azman; Emily A Kendall; Barun Mathema
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

3.  Pilot study: is the fear response the same in anorexia nervosa as in controls?

Authors:  C Laird Birmingham; Shelley Sidhu; John Anderson
Journal:  Eat Weight Disord       Date:  2018-03-14       Impact factor: 4.652

Review 4.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

5.  Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011.

Authors:  H E Jenkins; M Gegia; J Furin; I Kalandadze; U Nanava; T Chakhaia; T Cohen
Journal:  Euro Surveill       Date:  2014-03-20

6.  Effectiveness of contact investigations for tuberculosis control in Arkansas.

Authors:  Giorgio Guzzetta; Marco Ajelli; Zhenhua Yang; Leonard N Mukasa; Naveen Patil; Joseph H Bates; Denise E Kirschner; Stefano Merler
Journal:  J Theor Biol       Date:  2015-06-05       Impact factor: 2.691

7.  Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.

Authors:  M L Peterson; N R Gandhi; J Clennon; K N Nelson; N Morris; N Ismail; S Allana; A Campbell; J C M Brust; S C Auld; B Mathema; K Mlisana; P Moodley; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2019-06-01       Impact factor: 2.373

8.  High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.

Authors:  Helen E Jenkins; Valeriu Crudu; Viorel Soltan; Ana Ciobanu; Liliana Domente; Ted Cohen
Journal:  Eur Respir J       Date:  2014-02-20       Impact factor: 16.671

9.  Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Authors:  H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

Review 10.  Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis.

Authors:  Sara C Auld; N Sarita Shah; Ted Cohen; Neil A Martinson; Neel R Gandhi
Journal:  Respirology       Date:  2018-06-05       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.